Meanwhile, Eli Lilly also brought a separate application in the Ontario Court of Justice (Gen- eral Division), seeking a declaration that Novopharm's licence was terminated by virtue of its granting a sublicence to Apotex, contrary to the terms of the licence. Forget J. found that that ...